23 August 2010
Journal of Alzheimer’s Disease #18 on Index Copernicus™ Top 100 Journal List
Amsterdam, The Netherlands and San Antonio, TX, USA – International publisher IOS Press and the Editors-in-Chief of the Journal of Alzheimer’s Disease (JAD) are pleased to announce that with a 51.04 rating, the Journal has achieved a ranking of #18 on the Index Copernicus Top 10
23 August 2010
Rheumatoid arthritis signaling protein GM-CSF reverses Alzheimer’s disease in mouse model
Tampa, FL -- A signaling protein released during rheumatoid arthritis dramatically reduced Alzheimer’s disease pathology and reversed the memory impairment of mice bred to develop symptoms of the neurodegenerative disease, a new study by the University of South Florida reports.
13 June 2010
Can Alzheimer’s Disease Be Prevented? Researchers Explore Potential Interventions in a Special Issue of the Journal of Alzheimer’s Disease
Amsterdam, The Netherlands – Although effective treatment for Alzheimer’s disease (AD) has been slow to emerge, there has been substantial progress in identifying AD risk factors and developing treatments that might delay or prevent onset of the disease.
24 May 2010
Rudy J. Castellani, Jr., MD, Receives 2010 Alzheimer Award
Rudy J. Castellani, Jr., MD, has been chosen as recipient of the 2010 Alzheimer Award presented by the Journal of Alzheimer’s Disease in recognition of his outstanding work, “Reexamining Alzheimer’s Disease: Evidence for a Protective Role for Amyloid-β Protein Precursor and Amyloid-β” (J Alzheimers Dis 18, 447-452, 2009) by R.J. Castellani et al.
23 May 2010
Alcohol Consumption May Protect Against Risk of Alzheimer’s Disease, Particularly in Female Nonsmokers
A new study published this month in the Journal of Alzheimer's Disease suggests a protective effect of alcohol consumption on the risk of Alzheimer's disease, particularly in women who do not smoke.
16 May 2010
New Evidence Caffeine May Slow Alzheimer’s Disease and Other Dementias and Restore Cognitive Function
Amsterdam, The Netherlands –Although caffeine is the most widely consumed psychoactive drug worldwide, its potential beneficial effect for maintenance of proper brain functioning has only recently begun to be adequately appreciated.
19 April 2010
Bigger molecular-sized anesthetics do not promote amyloid-beta peptide micro-aggregation
Amsterdam, The Netherlands – Alzheimer's disease (AD) is a neurodegenerative disorder affecting millions of people worldwide and has become a major global concern. Uncontrolled oligomerization (aggregation) of Aβ peptide is the hallmark of AD and it is believed to be causally related to AD pat
18 April 2010
Alzheimer’s Drug Improves Cognitive Performance
According to a new analysis of the performance of a drug developed by the Mental Health Research Institute in partnership with Prana Biotechnology the drug is even more effective in reversing dementia symptoms than previously believed.
28 March 2010
Alzheimer’s rat created for human research
Montreal, Cananda –Prof. Claudio Cuello at McGill University and his collaborators have genetically manipulated rats that can emulate Alzheimer’s disease in humans, enabling research that will include the development of new treatments.
15 March 2010
Anesthesia increases risk of developing Alzheimer’s disease in patients with genetic predisposition
Madrid, Spain –The use of repetitive anesthesia with isoflurane (one of the most common anesthetics by inhalation) increases the risk of developing changes similar to those observed in AD brains in mice with mutations of the amyloid precursor protein (APP).
Pages
